Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Expanded the study's Locations section to include a comprehensive list of site locations across multiple regions. The update covers locations across the United States, Canada, Australia, and numerous other countries.
    Difference
    2%
    Check dated 2025-12-21T21:30:33.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed. This update changes only metadata/version information and does not affect study details or page functionality.
    Difference
    0.0%
    Check dated 2025-11-30T06:08:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Publications section now includes notes that publications are provided voluntarily and auto-filled from PubMed. The page revision is shown as Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-23T00:28:57.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The lapse in government funding notice has been removed from the page, and other content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-15T15:06:38.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Publications and results related to KEYNOTE-564 were added, including a 2024 NEJM article, and the study record dates were updated.
    Difference
    0.1%
    Check dated 2025-11-01T07:29:45.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Added a time-sensitive operating status notice and funding-related disclaimer, and updated the version to v3.2.0 (removing v3.1.0).
    Difference
    1%
    Check dated 2025-10-03T08:50:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.